—
C+
C+ The full Closelook — membership. Open the C+ overview

Fagron NV (FAGR.BR) — chart, structure and Closelook read

Home› Indices›
Pick a ticker to load its detail page.

Company snapshot — Fagron NV

FAGR.BR in five paragraphs: what it makes and sells, where it sits in the Closelook stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Fagron NV compounds and personalises pharmaceutical treatments for hospitals, pharmacies, clinics and patients worldwide, working through three segments: Essentials, Brands and Compounding Services. Its product range spans capsule and tablet excipients, dermatology and scar-care formulations, hair-loss treatments and a paediatric suspension base, alongside training for prescribers and pharmacists through its own academy. The company, formerly named Arseus, is based in Nazareth, Belgium.
Where it sits in the stack
Fagron carries no seat in our index and sits outside the AI build-out entirely; it belongs to the healthcare sleeve of our universe, under drug manufacturing for specialty and generic products, where compounding rather than mass production is the business.
Who it is priced against
Closelook's peer group has no entry for Fagron, so no comparison set or reasoning is on file here.
Why Closelook tracks it
Fagron holds no seat in any Closelook index, carries no score, and appears in none of the diary's editions or quotes; the diary notes it only through its chart structure readings.
What the diary watches
Whether the balance between its Essentials, Brands and Compounding Services segments shifts, since a move toward higher-margin branded and dermatology lines would change how the business reads.

Fagron NV (FAGR.BR) trades on the BR exchange in Belgium, classified under Healthcare.

The Closelook company score reads 51/100 composite (momentum 40, quality 53, valuation 61) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelook’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Signals for this name

Every Closelook reading that exists for FAGR.BR, from the same nightly bakes the boards use. Research diary readings, not advice.

Who it is priced against Healthcare · 8 names with week and year-to-date

Peer group

Healthcare

Scored names in the same sector from the Closelook universe.

Compared against FAGR.BR on the nightly bakes; the Peers tab ranks the cohort on the Closelook scores where it exists.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 55/100 · S&P 500 fund at 58, above its 50- and 200-day averagesEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-17
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 94th percentile of the window, +2.7% over 20 sessions. Factor regime → 2026-09-17
  • Sector × region Health care in Europe: +1.1% week · −3.6% month · +0.3% quarter · −6.5% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-16
  • Sovereign pressure Index 0.00 · down 0.41 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-17

FAQ · from the current data · as of 2026-09-18

Quick answers

What is Fagron NV (FAGR.BR)?

Fagron NV trades as FAGR.BR on the BR exchange (Belgium) and is classified under Healthcare in the Closelook research universe, as of the registry build of 2026-09-18.

Is FAGR.BR in a Closelook index?

Not currently — Fagron NV is tracked in the Closelook research universe but is not a constituent of a Closelook functional index as of 2026-09-18.

What is Fagron NV's Closelook composite score?

51 out of 100, with momentum 40, quality 53 and valuation 61 sub-scores, as of 2026-09-18. Scores are Closelook's own research readings, not ratings or investment advice.

Where does FAGR.BR trade against its moving averages?

Mixed moving-average stack: Trades -1.8% vs the 50-day and -1.6% vs the 200-day average, 12.3% below the 52-week high and +16.2% off the 52-week low. Computed from daily closes. As of 2026-09-17 — a technical state from the nightly Closelook bake, not advice. The Technical tab carries the full row.

What does Fagron NV do?

Fagron NV compounds and personalises pharmaceutical treatments for hospitals, pharmacies, clinics and patients worldwide, working through three segments: Essentials, Brands and Compounding Services. Its product range spans capsule and tablet excipients, dermatology and scar-care formulations, hair-loss treatments and a paediatric suspension base, alongside training for prescribers and pharmacists through its own academy. The company, formerly named Arseus, is based in Nazareth, Belgium. Closelook's peer group has no entry for Fagron, so no comparison set or reasoning is on file here.

Where does Fagron NV sit in the AI build-out?

Fagron carries no seat in our index and sits outside the AI build-out entirely; it belongs to the healthcare sleeve of our universe, under drug manufacturing for specialty and generic products, where compounding rather than mass production is the business. Fagron holds no seat in any Closelook index, carries no score, and appears in none of the diary's editions or quotes; the diary notes it only through its chart structure readings.

What does this page show?

A live price chart with SMA overlays and drawing tools for FAGR.BR, performance metrics, index-membership context and the Closelook structure read — an investment research diary view, not investment advice.

Related in the Closelook universe